文献速递乳房整形与再造显微修复重建

上臂淋巴水肿患者的延期乳房再造:系统综述与汇总分析

Delayed Breast Reconstruction on Patients With Upper Extremity Lymphedema: A Systematic Review of the Literature and Pooled Analysis.
PubMed 文献 · Ann Plast Surg · 2018-01-01

该系统综述与汇总分析检索截至2016年11月11日的文献,纳入8项研究(1项病例报告、7项病例系列,样本量3至38例),评估延期乳房再造对已发生的乳腺癌相关上臂淋巴水肿的影响。汇总分析显示58%的患者报告改善;敏感性分析中,同时接受乳房再造与血管化淋巴结移植(VLNT)者84%(95%CI 0.74-0.95)报告改善,仅接受乳房再造者22%(95%CI 0.12-0.32)报告改善。作者认为自体乳房再造中的VLNT部分可能是导致淋巴水肿改善的最大contributing因素。

要点

  • 纳入8项研究(1项病例报告、7项病例系列,样本量3–38例),评估延期乳房再造对已发生上臂淋巴水肿的影响。
  • 汇总分析中58%的患者在乳房再造后(伴或不伴VLNT)报告淋巴水肿改善。
  • 敏感性分析:乳房再造联合VLNT者84%(95%CI 0.74-0.95)报告改善,仅乳房再造者22%(95%CI 0.12-0.32)报告改善。

核心结论

  • 本综述总结了延期乳房再造对已发生淋巴水肿疗效的现有证据,自体乳房再造中的VLNT部分可能是导致淋巴水肿改善的最大contributing因素。

研究设计与样本

  • 遵循PRISMA指南,系统检索PubMed、Scopus、EMBASE和Google Scholar截至2016年11月11日的相关研究,初筛934篇独特文章,对37篇进行全文与参考文献筛选。
  • 最终纳入8项研究:1项病例报告,7项病例系列,样本量3至38例患者。
  • 采用随机效应模型进行汇总分析与敏感性分析。

主要发现

  • 汇总分析显示58%的患者在乳房再造后(伴或不伴VLNT)报告淋巴水肿改善。
  • 敏感性分析显示,接受乳房再造联合VLNT的患者中84%(95%CI 0.74-0.95)报告改善。
  • 仅接受乳房再造的患者中22%(95%CI 0.12-0.32)报告改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast cancer-related lymphedema (BCRL) is a debilitating condition with morbidity, hindered quality of life, and increased health-related costs. Experimental studies support the use of musculocutaneous flaps for managing animal models with lymphedema. Although vascularized lymph node transfer (VLNT) and lymphovenous anastomosis are used to surgically treat patients with lymphedema, it is not known whether musculocutaneous or adipocutaneous flaps (eg, delayed autologous breast reconstruction) are effective for treating refractory upper extremity BCRL. We conducted a systematic review and pooled analysis to assess the impact of delayed breast reconstruction on developed BCRL. METHODS: Following PRISMA guidelines, we systematically searched PubMed, Scopus, EMBASE, and Google Scholar databases for relevant studies published through November 11, 2016. We screened 934 unique articles. Of these, we conducted full-text and reference screening on 37 articles. We then performed a pooled and sensitivity analysis using random effects. RESULTS: Eight studies met our inclusion criteria. One study was a case report; 7 studies were case series with sample sizes ranging from 3 to 38 patients. According to our pooled analysis 58% of patients reported improvement after breast reconstruction with or without VLNT. Sensitivity analysis revealed that 84% (95% confidence interval, 0.74-0.95) of patients who underwent breast reconstruction and VLNT reported improvement, whereas only 22% (95% confidence interval, 0.12-0.32) of those who had breast reconstruction alone reported improvement. CONCLUSIONS: Our review summarizes the current evidence regarding the effect of delayed breast reconstruction on established lymphedema. The VLNT component of the autologous breast reconstruction procedures may be the largest contributing factor leading to lymphedema improvement.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Siotos C, Hassanein AH, Bello RJ, et al. Delayed Breast Reconstruction on Patients With Upper Extremity Lymphedema: A Systematic Review of the Literature and Pooled Analysis. Ann Plast Surg. 2018. PMID: 29944525. doi:10.1097/SAP.0000000000001542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。